Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
John Maraganore
Fierce Biotech
82% of industry CEOs concerned about FDA's abilities: survey
Biotech CEOs worry that added volatility in an already high-risk industry will discourage investment or will drive it to other countries.
Gabrielle Masson
Nov 21, 2025 4:38pm
Fierce Biotech
Biotech leaders urge FDA to not restrict abortion pill access
Jul 2, 2025 2:14pm
Most influential people in biopharma—the entrepreneurs
May 16, 2022 3:00am
Alnylam founder Maraganore, successor Greenstreet get pay bumps
Apr 7, 2022 10:52am
Alnylam founding CEO Maraganore steps down
Oct 28, 2021 11:05am
Alnylam's CEO scored $7.8M—or $13.6M—in 2020. Who's counting?
Apr 15, 2021 11:34am
